OWC Pharmaceutical Research Corp (OWCP)

[PhenixBleu]

After Bignitz and Hirsch left in March 2020, they appointed replacement Zvi Riterband. Ziv Turner reappeared June 2020 and took over the Chairman/CEO roles last Summer.

In April 2020, DGF filed for Preliminary Injunction in SDNY. Upon Stipulation, Turner was Ordered by the SDNY Court to provide an unaudited financial statement. He did not report any financial information.

https://www.docketbird.com/court-cases/Discover-Growth-Fund-LLC-v-Owc-Pharmaceutical-Research-Corp/nysd-1:2020-cv-02857

As a result of defaulted 2020 DGF loan agreements (totaling $200k) by Riterband/Turner, DGF filed SEC documents in 2021 removing Ziv Turner and replacing him, in all roles, with David Kugelman. DGF/Kugelman filed Complaint in Delaware seeking authority for these 8-K/13D actions.

We are waiting on ruling(s) from Delaware, where OWCP is incorporated.

My Stickie has info on the Delaware case. My responses to the stickie provider further relevant information.